Nanobodies are single domain antibodies derived from the variable domains of camelid heavy chain-only antibodies (VHHs). They have emerged as versatile research tools with applications in diverse fields from structural biology and cell biology to diagnostics and therapy.

While the value of nanobodies is well recognized in specific research communities, expertise on the practical development and use of these tools is dispersed over disciplines with little exchange. For the first time, this symposium brings together scientists from diverse disciplines to exchange knowledge, methods, and tools to advance the field and initiate new collaborations. To maximize overlap and synergistic research endeavors, the symposium will feature invited international speakers as well as additional oral presentations and posters selected from the registered participants.

 

This symposium is kindly supported by the Fritz Thyssen Foundation.